News
Eli Lilly: The third phase clinical trial of Verzenio + endocrine therapy showed statistically significant and substantial clinical improvement for specific breast cancer patients
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments